LAMBRECHTS; Diether

Patent Applications and Registrations

Patent applications and USPTO patent grants for LAMBRECHTS; Diether.The latest application filed is for "markers for determining tumor hypoxia".

Company Profile

4.4.15

LAMBRECHTS; Diether - Kessel-Lo BE
Lambrechts; Diether - Leuven BE
Lambrechts; Diether - Kessel-lo Leuven

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Markers for Determining Tumor Hypoxia App 20220259677 - LAMBRECHTS; Diether ; et al.	2022-08-18
Retrotransposon Biomarkers App 20220090209 - Lambrechts; Diether ; et al.	2022-03-24
Method for predicting the outcome of a treatment with aflibercept of a patient suspected to suffer from a cancer Grant 11,208,461 - Chiron-Blondel , et al. December 28, 2	2021-12-28
Predicting Chronic Allograft Injury Through Ischemia-induced Dna Methylation App 20210388441 - LAMBRECHTS; Diether ; et al.	2021-12-16
Novel Markers for Detecting Microsatellite Instability in Cancer and Determining Synthetic Lethality with Inhibition of the DNA Base Excision Repair Pathway App 20200255913 - Lambrechts; Diether	2020-08-13
Method For Predicting The Outcome Of A Treatment With Aflibercept Of A Patient Suspected To Suffer From A Cancer App 20200157181 - CHIRON-BLONDEL; Marielle ; et al.	2020-05-21
Markers for detecting microsatellite instability in cancer and determining synthetic lethality with inhibition of the DNA base excision repair pathway Grant 10,633,707 - Lambrechts	2020-04-28
Means And Methods For Anti-vegf Therapy App 20200095641 - Lambrechts; Diether ; et al.	2020-03-26
IL-8 level based method of predicting the outcome of colon cancer treatment Grant 10,501,523 - Chiron-Blondel , et al. Dec	2019-12-10
Microsatellite instability markers in detection of cancer Grant 10,294,529 - Lambrechts	2019-05-21
Markers for Determining Tumor Hypoxia App 20180051345 - LAMBRECHTS; Diether ; et al.	2018-02-22
Method For Predicting The Outcome Of A Treatment With Aflibercept Of A Patient Suspected To Suffer From A Cancer App 20170121387 - CHIRON-BLONDEL; Marielle ; et al.	2017-05-04
Responsiveness To Angiogenesis Inhibitors App 20170066822 - Carmeliet; Peter ; et al.	2017-03-09
Novel Markers For Detecting Microsatellite Instability In Cancer And Determining Synthetic Lethality With Inhibition Of The Dna Base Excision Repair Pathway App 20150045369 - Lambrechts; Diether	2015-02-12
Responsiveness To Angiogenesis Inhibitors App 20150004136 - Carmeliet; Peter ; et al.	2015-01-01
Responsiveness To Angiogenesis Inhibitors App 20140294768 - de Haas; Sanne Lysbet ; et al.	2014-10-02
Method For Predicting Risk Of Hypertension Associated With Anti-angiogenesis Therapy App 20140294811 - de Haas; Sanne Lysbet ; et al.	2014-10-02
Microsatellite Instability Markers In Detection Of Cancer App 20130267426 - Lambrechts; Diether	2013-10-10
Responsiveness To Angiogenesis Inhibitors App 20120195858 - Foernzler; Dorothee ; et al.	2012-08-02

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.